Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wai

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 21, 2005
Reversibility of experimental rabbit liver cirrhosis by portal collagenase administrationBo Jin, Harvey J Alter, Zhi-Cheng Zhang, et al.
Plos One|November 3, 2010
Profile of acute infectious markers in sporadic hepatitis EShoujie Huang, Xuefeng Zhang, Hanmin Jiang, et al.
BMC Infectious Diseases|July 7, 2026
Hepatitis E virus seroprevalence in South Africa: a multi-site study among HIV-negative and HIV-positive adults and age-stratified children (2-17 Years)Tarun Saluja, Nigus Telele, Elizabeth Hellström, et al.
The Journal of Infectious Diseases|March 27, 2024
A Phase 1, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of HEV-239 (Hecolin) Vaccine in Healthy US AdultsCarol M Kao, Christina A Rostad, Lauren E Nolan, et al.
The Journal of Infectious Diseases|November 19, 2003
Investigation of SEN virus infection in patients with cryptogenic acute liver failure, hepatitis-associated aplastic anemia, or acute and chronic non-A-E hepatitisTakeji Umemura, Eiji Tanaka, George Ostapowicz, et al.
Nature Medicine|November 4, 2000
A peptide-doxorubicin 'prodrug' activated by prostate-specific antigen selectively kills prostate tumor cells positive for prostate-specific antigen in vivoD DeFeo-Jones, V M Garsky, B K Wong, et al.
The New England Journal of Medicine|March 5, 2015
Long-term efficacy of a hepatitis E vaccineJun Zhang, Xue-Feng Zhang, Shou-Jie Huang, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 21, 2005
Reversibility of experimental rabbit liver cirrhosis by portal collagenase administrationBo Jin, Harvey J Alter, Zhi-Cheng Zhang, et al.
Plos One|November 3, 2010
Profile of acute infectious markers in sporadic hepatitis EShoujie Huang, Xuefeng Zhang, Hanmin Jiang, et al.
BMC Infectious Diseases|July 7, 2026
Hepatitis E virus seroprevalence in South Africa: a multi-site study among HIV-negative and HIV-positive adults and age-stratified children (2-17 Years)Tarun Saluja, Nigus Telele, Elizabeth Hellström, et al.
The Journal of Infectious Diseases|March 27, 2024
A Phase 1, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of HEV-239 (Hecolin) Vaccine in Healthy US AdultsCarol M Kao, Christina A Rostad, Lauren E Nolan, et al.
The Journal of Infectious Diseases|November 19, 2003
Investigation of SEN virus infection in patients with cryptogenic acute liver failure, hepatitis-associated aplastic anemia, or acute and chronic non-A-E hepatitisTakeji Umemura, Eiji Tanaka, George Ostapowicz, et al.
Nature Medicine|November 4, 2000
A peptide-doxorubicin 'prodrug' activated by prostate-specific antigen selectively kills prostate tumor cells positive for prostate-specific antigen in vivoD DeFeo-Jones, V M Garsky, B K Wong, et al.
The New England Journal of Medicine|March 5, 2015
Long-term efficacy of a hepatitis E vaccineJun Zhang, Xue-Feng Zhang, Shou-Jie Huang, et al.
Pageof 4